Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles

• Goepfert P,
• Elizaga M,
• Montefiori D,
• Hural J,
• DeRosa S,
• Tomaras G,
• Seaton K,
• Sato A,
• Ouedraogo L,
• Donastorg Y,
• Cardinali M,
• Lama J,
• Baden L,
• Keefer M,
• McElrath J,
• Kalams S,
• Robinson H

Affiliations

Goepfert P

Elizaga M

Montefiori D

Hural J

DeRosa S

Tomaras G

Seaton K

Sato A

Ouedraogo L

Donastorg Y

Cardinali M

Lama J

Baden L

Keefer M

McElrath J

Kalams S

Robinson H